Persistence of Immunity When Using Different Human Papillomavirus Vaccination Schedules and Booster-Dose Effects 5 Years After Primary Vaccination

Eduardo Lazcano-Ponce,Leticia Torres-Ibarra,Aurelio Cruz Valdez,Jorge Salmerón,Tonatiuh Barrientos-Gutierrez,Javier Prado-Galbarro,Margaret Stanley,Nubia Muñoz,Rolando Herrero,Mauricio Hernández-Ávila

Persistence of Immunity When Using Different Human Papillomavirus Vaccination Schedules and Booster-Dose Effects 5 Years After Primary Vaccination

2019

Eduardo Lazcano-Ponce
Leticia Torres-Ibarra
Aurelio Cruz Valdez
Jorge Salmerón
Tonatiuh Barrientos-Gutierrez
Javier Prado-Galbarro
Margaret Stanley
Nubia Muñoz
Rolando Herrero
Mauricio Hernández-Ávila

Background There are limited data regarding the duration of immunity induced by different human papillomavirus (HPV) vaccination schedules and the immunogenicity of a booster dose of both bivalent HPV vaccine (bHPV) or quadrivalent HPV vaccine (qHPV).

Keywords:

Immunity
Antibody titer
Antibody
Virology
Immunology
Immunogenicity
Persistence (computer science)
Vaccination
Human Papilloma Virus Vaccine
Booster dose
Medicine
Pediatrics
Booster (rocketry)
Clinical trial
Vaccination schedule

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations